system
Medical AI Inquiry: You was designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.  Labels: BACKGROUND, METHODS, RESULTS. Meshes: Accelerometry, Adrenergic beta-2 Receptor Agonists, Aged, Bronchodilator Agents, Exercise Test, Female, Forced Expiratory Volume, Humans, Indans, Male, Motor Activity, Pulmonary Disease, Chronic Obstructive, Quinolones.
user
Does indacaterol improve daily physical activity in patients with chronic obstructive pulmonary disease? Context: The current mainstay of therapy for chronic obstructive pulmonary disease (COPD) is long-acting bronchodilators. To date, the effect of indacaterol, a β2-agonist, on activities of daily living in COPD patients is not well understood. The aim of this study was to evaluate the efficacy of indacaterol with regard to activities of daily living in patients with COPD. In this nonrandomized open-label study, 23 patients with COPD were instructed to carry an accelerometer for 4 weeks without indacaterol therapy and then for another period of 4 weeks while receiving indacaterol therapy. The number of steps, duration of moderate or greater physical activity, and energy expenditure were significantly increased after treatment with indacaterol compared with baseline data in all patients with COPD; the metabolic equivalent of task was also significantly enhanced after treatment with indacaterol.
assistant
This study provides early evidence that indacaterol improves daily physical activity in patients with COPD. Final Decision: yes